News | Information Technology | May 04, 2020

Google Cloud and Coviant Software Join Forces for Automating Healthcare Data Transfer and Processing

Coviant Software, a provider of managed file transfer software that provides an easy way to automate, secure, manage, and audit file transfers while maintaining the highest levels of security and compliance, has extended its Diplomat MFT product to support the Google Cloud Healthcare API. 

May 4, 2020 — Coviant Software, a provider of managed file transfer software that provides an easy way to automate, secure, manage, and audit file transfers while maintaining the highest levels of security and compliance, has extended its Diplomat MFT product to support the Google Cloud Healthcare API.  This move follows quickly after the announcement by Google that the Cloud Healthcare API is now generally available, making Coviant Software the first and only MFT vendor to fully support Google Cloud Healthcare API for data exchange.

The Google Cloud Healthcare API provides a suite of capabilities designed to enable standardized data exchanges between healthcare applications and solutions built on Google Cloud.  It provides support for FHIR, DICOM, and HL7 data integration, and is fully HIPAA compliant.  Once stored in data sets on the Google Cloud Platform, the healthcare data can be de-identified for privacy, and can be easily integrated into data processing, analytics, and AI on the platform.

Coviant Software Diplomat MFT provides automated, secure file transfers from any endpoint, to any endpoint.  "Diplomat MFT already supports easily transferring data to Google Cloud Storage," said Greg Hoffer, CEO of Coviant Software.  "When we learned that the Google Cloud Healthcare API plays an important role in the management, analytics, and exchange of this important and sensitive data, we quickly extended our solution to make integration into the Google Cloud Healthcare API as simple as ticking a box and filling in a few fields.  Now healthcare customers can leverage the cost savings and security of Google Cloud storage and easily take advantage of the power and flexibility of Google Cloud Healthcare API."

For more information: www.coviantsoftware.com

Related Content

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation.

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation. Higher signal intensity can be seen in the central white matter, particularly for the 31-week gestation infant. The bottom panels display the corresponding slices with objectively segmented DWMA in yellow. The 27-week infant (left) was diagnosed with mild DWMA, the 26-week infant (center) was diagnosed with moderate DWMA, and the 31-week infant had severe DWMA. Image courtesy of Cincinnati Children's and Nature Scientific Reports

News | Magnetic Resonance Imaging (MRI) | October 01, 2020
October 1, 2020 — As many as 70% of very premature infants (born earlier than 32 weeks gestation) show signs of white
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

Feature | Artificial Intelligence | September 29, 2020 | Joe Fornadel, J.D., and Wes Moran, J.D.
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady
The FDA Center for Devices and Radiological Health's COVID-19 response by the numbers between January 1 and September 18, 2020.

The FDA Center for Devices and Radiological Health's COVID-19 response by the numbers between January 1 and September 18, 2020. Graphic courtesy of FDA

News | Coronavirus (COVID-19) | September 29, 2020
September 29, 2020 — On September 28, FDA Commissioner of Food and Drugs...
Lung and respiratory health pioneer paves way for more precise care of complex respiratory conditions
News | Artificial Intelligence | September 25, 2020
September 25, 2020 — VIDA Diagnostics, Inc. announced that it has received 510(k) clearance from the Food and Drug Ad
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been virtualizing various aspects of our lives for many years, but the circumstances of this one has moved almost all of our lives into the virtual realm.

Getty Images

Feature | Radiology Education | September 18, 2020 | By Jef Williams
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”.
As the silos of data and diagnostic imaging PACS systems are being collapsed and secured, the modular enterprise imaging platform approach is gaining significance, offering systemness and security
Feature | Coronavirus (COVID-19) | September 18, 2020 | By Anjum M. Ahmed, M.D., MBBS, MBA, MIS
COVID-19 is now everywhere, and these are the lo
Cloud and cloud-native architecture is the future for computing solutions in EI applications

Getty Images

Feature | Enterprise Imaging | September 18, 2020 | By Henri “Rik” Premo
With over five years of presence in the rapidly expanding...